[18 F]fluorodeoxyglucose Uptake Patterns in Lung Before Radiotherapy Identify Areas More Susceptible to Radiation-Induced Lung Toxicity in Non-Small-Cell Lung Cancer Patients

Purpose Our hypothesis was that pretreatment inflammation in the lung makes pulmonary tissue more susceptible to radiation damage. The relationship between pretreatment [18 F]fluorodeoxyglucose ([18 F]FDG) uptake in the lungs (as a surrogate for inflammation) and the delivered radiation dose and rad...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of radiation oncology, biology, physics biology, physics, 2011-11, Vol.81 (3), p.698-705
Hauptverfasser: Petit, Steven F., M.Sc, van Elmpt, Wouter J.C., Ph.D, Oberije, Cary J.G., M.Sc, Vegt, Erik, M.D, Dingemans, Anne-Marie C., Ph.D, Lambin, Philippe, M.D., Ph.D, Dekker, André L.A.J., Ph.D, De Ruysscher, Dirk, M.D., Ph.D
Format: Artikel
Sprache:eng
Schlagworte:
Age
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 705
container_issue 3
container_start_page 698
container_title International journal of radiation oncology, biology, physics
container_volume 81
creator Petit, Steven F., M.Sc
van Elmpt, Wouter J.C., Ph.D
Oberije, Cary J.G., M.Sc
Vegt, Erik, M.D
Dingemans, Anne-Marie C., Ph.D
Lambin, Philippe, M.D., Ph.D
Dekker, André L.A.J., Ph.D
De Ruysscher, Dirk, M.D., Ph.D
description Purpose Our hypothesis was that pretreatment inflammation in the lung makes pulmonary tissue more susceptible to radiation damage. The relationship between pretreatment [18 F]fluorodeoxyglucose ([18 F]FDG) uptake in the lungs (as a surrogate for inflammation) and the delivered radiation dose and radiation-induced lung toxicity (RILT) was investigated. Methods and Materials We retrospectively studied a prospectively obtained cohort of 101 non-small-cell lung cancer patients treated with (chemo)radiation therapy (RT). [18 F]FDG-positron emission tomography-computed tomography (PET-CT) scans used for treatment planning were studied. Different parameters were used to describe [18 F]FDG uptake patterns in the lungs, excluding clinical target volumes, and the interaction with radiation dose. An increase in the dyspnea grade of 1 (Common Terminology Criteria for Adverse Events version 3.0) or more points compared to the pre-RT score was used as an endpoint for analysis of RILT. The effect of [18 F]FDG and CT-based variables, dose, and other patient or treatment characteristics that effected RILT was studied using logistic regression. Results Increased lung density and pretreatment [18 F]FDG uptake were related to RILT after RT with univariable logistic regression. The 95th percentile of the [18 F]FDG uptake in the lungs remained significant in multivariable logistic regression ( p = 0.016; odds ratio [OR] = 4.3), together with age ( p = 0.029; OR = 1.06), and a pre-RT dyspnea score of ≥1 ( p = 0.005; OR = 0.20). Significant interaction effects were demonstrated among the 80th, 90th, and 95th percentiles and the relative lung volume receiving more than 2 and 5 Gy. Conclusions The risk of RILT increased with the 95th percentile of the [18 F]FDG uptake in the lungs, excluding clinical tumor volume (OR = 4.3). The effect became more pronounced as the fraction of the 5%, 10%, and 20% highest standardized uptake value voxels that received more than 2 Gy to 5 Gy increased. Therefore, the risk of RILT may be decreased by applying sophisticated radiotherapy techniques to avoid areas in the lung with high [18 F]FDG uptake.
doi_str_mv 10.1016/j.ijrobp.2010.06.016
format Article
fullrecord <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_osti_scitechconnect_21590429</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0360301610008655</els_id><sourcerecordid>1257888487</sourcerecordid><originalsourceid>FETCH-LOGICAL-c553t-b4d1b8cdef95af4bcce16c7e2dfcb18303565c6123c0f43d854798e8f4eaaffc3</originalsourceid><addsrcrecordid>eNqFktuKFDEQhhtR3HH1DUQaRPCmx6SP6RthHVwdGA84uyCIhHRS2U1vJmmTtGy_lM9o2h4VvPEqUPmq6q_6K0keY7TGCNcv-rXqne2GdY5iCNXrGLyTrDBp2qyoqs93kxUqapQVMX6SPPC-Rwhh3JT3k5McEVLinKySH18wSc-_Sj1aZwXY2-lKj9x6SC-HwG4g_chCAGd8qky6G81V-gqkdZB-YkLZcA2ODVO6FWCCklN65oD59N0M7EfPYQiq05AG-4tnQVmTbY0YOYil2oW9VVyFaS7_Pn7uD0zrbANaL_8bZji4WYWKLfzD5J5k2sOj43uaXJ6_vti8zXYf3mw3Z7uMV1URsq4UuCNcgGwrJsuOc8A1byAXkneYFKio6orXOC84kmUhSFU2LQEiS2BMSl6cJk-XutYHRX1UCPyaW2OAB5rjqkVl3kbq-UINzn4bwQd6UHForZkBO3qK86ohcdOkiWi5oNxZ7x1IOjh1YG6iGNHZT9rTxU86-0lRTWMwpj05dhi7A4g_Sb8NjMCzI8A8Z1q6uC_l_3Jlg5qmnaW-XDiIW_uuwM1DQdytUG6eSVj1PyX_FuBaGRV73sAEvrejM9ERiqnPKaL7-fbm08Px6kgdXfkJtc3X_w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1257888487</pqid></control><display><type>article</type><title>[18 F]fluorodeoxyglucose Uptake Patterns in Lung Before Radiotherapy Identify Areas More Susceptible to Radiation-Induced Lung Toxicity in Non-Small-Cell Lung Cancer Patients</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Petit, Steven F., M.Sc ; van Elmpt, Wouter J.C., Ph.D ; Oberije, Cary J.G., M.Sc ; Vegt, Erik, M.D ; Dingemans, Anne-Marie C., Ph.D ; Lambin, Philippe, M.D., Ph.D ; Dekker, André L.A.J., Ph.D ; De Ruysscher, Dirk, M.D., Ph.D</creator><creatorcontrib>Petit, Steven F., M.Sc ; van Elmpt, Wouter J.C., Ph.D ; Oberije, Cary J.G., M.Sc ; Vegt, Erik, M.D ; Dingemans, Anne-Marie C., Ph.D ; Lambin, Philippe, M.D., Ph.D ; Dekker, André L.A.J., Ph.D ; De Ruysscher, Dirk, M.D., Ph.D</creatorcontrib><description>Purpose Our hypothesis was that pretreatment inflammation in the lung makes pulmonary tissue more susceptible to radiation damage. The relationship between pretreatment [18 F]fluorodeoxyglucose ([18 F]FDG) uptake in the lungs (as a surrogate for inflammation) and the delivered radiation dose and radiation-induced lung toxicity (RILT) was investigated. Methods and Materials We retrospectively studied a prospectively obtained cohort of 101 non-small-cell lung cancer patients treated with (chemo)radiation therapy (RT). [18 F]FDG-positron emission tomography-computed tomography (PET-CT) scans used for treatment planning were studied. Different parameters were used to describe [18 F]FDG uptake patterns in the lungs, excluding clinical target volumes, and the interaction with radiation dose. An increase in the dyspnea grade of 1 (Common Terminology Criteria for Adverse Events version 3.0) or more points compared to the pre-RT score was used as an endpoint for analysis of RILT. The effect of [18 F]FDG and CT-based variables, dose, and other patient or treatment characteristics that effected RILT was studied using logistic regression. Results Increased lung density and pretreatment [18 F]FDG uptake were related to RILT after RT with univariable logistic regression. The 95th percentile of the [18 F]FDG uptake in the lungs remained significant in multivariable logistic regression ( p = 0.016; odds ratio [OR] = 4.3), together with age ( p = 0.029; OR = 1.06), and a pre-RT dyspnea score of ≥1 ( p = 0.005; OR = 0.20). Significant interaction effects were demonstrated among the 80th, 90th, and 95th percentiles and the relative lung volume receiving more than 2 and 5 Gy. Conclusions The risk of RILT increased with the 95th percentile of the [18 F]FDG uptake in the lungs, excluding clinical tumor volume (OR = 4.3). The effect became more pronounced as the fraction of the 5%, 10%, and 20% highest standardized uptake value voxels that received more than 2 Gy to 5 Gy increased. Therefore, the risk of RILT may be decreased by applying sophisticated radiotherapy techniques to avoid areas in the lung with high [18 F]FDG uptake.</description><identifier>ISSN: 0360-3016</identifier><identifier>EISSN: 1879-355X</identifier><identifier>DOI: 10.1016/j.ijrobp.2010.06.016</identifier><identifier>PMID: 20884128</identifier><identifier>CODEN: IOBPD3</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; Age ; Age Factors ; Aged ; Aged, 80 and over ; ANTIMETABOLITES ; BETA DECAY RADIOISOTOPES ; BETA-PLUS DECAY RADIOISOTOPES ; Biological and medical sciences ; BODY ; Carcinoma, Non-Small-Cell Lung - diagnostic imaging ; Carcinoma, Non-Small-Cell Lung - metabolism ; Carcinoma, Non-Small-Cell Lung - radiotherapy ; CAT SCANNING ; Chemoradiotherapy ; COMPUTERIZED TOMOGRAPHY ; DIAGNOSTIC TECHNIQUES ; DISEASES ; DOSES ; DRUGS ; Dyspnea ; Dyspnea - etiology ; EMISSION COMPUTED TOMOGRAPHY ; Female ; FLUORINE 18 ; FLUORINE ISOTOPES ; FLUORODEOXYGLUCOSE ; Fluorodeoxyglucose (FDG) ; Fluorodeoxyglucose F18 - pharmacokinetics ; HAZARDS ; Hematology, Oncology and Palliative Medicine ; HOURS LIVING RADIOISOTOPES ; Humans ; HYPOTHESIS ; INFLAMMATION ; ISOMERIC TRANSITION ISOTOPES ; ISOTOPES ; LIGHT NUCLEI ; Logistic Models ; Lung ; Lung - diagnostic imaging ; Lung - metabolism ; Lung - radiation effects ; Lung cancer ; Lung Neoplasms - diagnostic imaging ; Lung Neoplasms - metabolism ; Lung Neoplasms - radiotherapy ; LUNGS ; Male ; Medical sciences ; MEDICINE ; Middle Aged ; Multimodal Imaging - methods ; NANOSECONDS LIVING RADIOISOTOPES ; NEOPLASMS ; NUCLEAR MEDICINE ; NUCLEI ; ODD-ODD NUCLEI ; Odds Ratio ; ORGANS ; PATHOLOGICAL CHANGES ; Pneumology ; PNEUMONITIS ; POSITRON COMPUTED TOMOGRAPHY ; Positron emission tomography (PET) ; Positron-Emission Tomography ; Radiation ; RADIATION DOSES ; RADIATION EFFECTS ; Radiation Pneumonitis - diagnostic imaging ; Radiation Pneumonitis - metabolism ; Radiation-induced lung toxicity (RILT) ; RADIOISOTOPES ; RADIOLOGY ; RADIOLOGY AND NUCLEAR MEDICINE ; Radiopharmaceuticals - pharmacokinetics ; RADIOTHERAPY ; Respiration ; RESPIRATORY SYSTEM ; Respiratory system : syndromes and miscellaneous diseases ; Retrospective Studies ; SYMPTOMS ; THERAPY ; TOMOGRAPHY ; Tomography, X-Ray Computed ; TOXICITY ; Tumors ; Tumors of the respiratory system and mediastinum</subject><ispartof>International journal of radiation oncology, biology, physics, 2011-11, Vol.81 (3), p.698-705</ispartof><rights>Elsevier Inc.</rights><rights>2011 Elsevier Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c553t-b4d1b8cdef95af4bcce16c7e2dfcb18303565c6123c0f43d854798e8f4eaaffc3</citedby><cites>FETCH-LOGICAL-c553t-b4d1b8cdef95af4bcce16c7e2dfcb18303565c6123c0f43d854798e8f4eaaffc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ijrobp.2010.06.016$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24707799$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20884128$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/21590429$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Petit, Steven F., M.Sc</creatorcontrib><creatorcontrib>van Elmpt, Wouter J.C., Ph.D</creatorcontrib><creatorcontrib>Oberije, Cary J.G., M.Sc</creatorcontrib><creatorcontrib>Vegt, Erik, M.D</creatorcontrib><creatorcontrib>Dingemans, Anne-Marie C., Ph.D</creatorcontrib><creatorcontrib>Lambin, Philippe, M.D., Ph.D</creatorcontrib><creatorcontrib>Dekker, André L.A.J., Ph.D</creatorcontrib><creatorcontrib>De Ruysscher, Dirk, M.D., Ph.D</creatorcontrib><title>[18 F]fluorodeoxyglucose Uptake Patterns in Lung Before Radiotherapy Identify Areas More Susceptible to Radiation-Induced Lung Toxicity in Non-Small-Cell Lung Cancer Patients</title><title>International journal of radiation oncology, biology, physics</title><addtitle>Int J Radiat Oncol Biol Phys</addtitle><description>Purpose Our hypothesis was that pretreatment inflammation in the lung makes pulmonary tissue more susceptible to radiation damage. The relationship between pretreatment [18 F]fluorodeoxyglucose ([18 F]FDG) uptake in the lungs (as a surrogate for inflammation) and the delivered radiation dose and radiation-induced lung toxicity (RILT) was investigated. Methods and Materials We retrospectively studied a prospectively obtained cohort of 101 non-small-cell lung cancer patients treated with (chemo)radiation therapy (RT). [18 F]FDG-positron emission tomography-computed tomography (PET-CT) scans used for treatment planning were studied. Different parameters were used to describe [18 F]FDG uptake patterns in the lungs, excluding clinical target volumes, and the interaction with radiation dose. An increase in the dyspnea grade of 1 (Common Terminology Criteria for Adverse Events version 3.0) or more points compared to the pre-RT score was used as an endpoint for analysis of RILT. The effect of [18 F]FDG and CT-based variables, dose, and other patient or treatment characteristics that effected RILT was studied using logistic regression. Results Increased lung density and pretreatment [18 F]FDG uptake were related to RILT after RT with univariable logistic regression. The 95th percentile of the [18 F]FDG uptake in the lungs remained significant in multivariable logistic regression ( p = 0.016; odds ratio [OR] = 4.3), together with age ( p = 0.029; OR = 1.06), and a pre-RT dyspnea score of ≥1 ( p = 0.005; OR = 0.20). Significant interaction effects were demonstrated among the 80th, 90th, and 95th percentiles and the relative lung volume receiving more than 2 and 5 Gy. Conclusions The risk of RILT increased with the 95th percentile of the [18 F]FDG uptake in the lungs, excluding clinical tumor volume (OR = 4.3). The effect became more pronounced as the fraction of the 5%, 10%, and 20% highest standardized uptake value voxels that received more than 2 Gy to 5 Gy increased. Therefore, the risk of RILT may be decreased by applying sophisticated radiotherapy techniques to avoid areas in the lung with high [18 F]FDG uptake.</description><subject>Adult</subject><subject>Age</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>ANTIMETABOLITES</subject><subject>BETA DECAY RADIOISOTOPES</subject><subject>BETA-PLUS DECAY RADIOISOTOPES</subject><subject>Biological and medical sciences</subject><subject>BODY</subject><subject>Carcinoma, Non-Small-Cell Lung - diagnostic imaging</subject><subject>Carcinoma, Non-Small-Cell Lung - metabolism</subject><subject>Carcinoma, Non-Small-Cell Lung - radiotherapy</subject><subject>CAT SCANNING</subject><subject>Chemoradiotherapy</subject><subject>COMPUTERIZED TOMOGRAPHY</subject><subject>DIAGNOSTIC TECHNIQUES</subject><subject>DISEASES</subject><subject>DOSES</subject><subject>DRUGS</subject><subject>Dyspnea</subject><subject>Dyspnea - etiology</subject><subject>EMISSION COMPUTED TOMOGRAPHY</subject><subject>Female</subject><subject>FLUORINE 18</subject><subject>FLUORINE ISOTOPES</subject><subject>FLUORODEOXYGLUCOSE</subject><subject>Fluorodeoxyglucose (FDG)</subject><subject>Fluorodeoxyglucose F18 - pharmacokinetics</subject><subject>HAZARDS</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>HOURS LIVING RADIOISOTOPES</subject><subject>Humans</subject><subject>HYPOTHESIS</subject><subject>INFLAMMATION</subject><subject>ISOMERIC TRANSITION ISOTOPES</subject><subject>ISOTOPES</subject><subject>LIGHT NUCLEI</subject><subject>Logistic Models</subject><subject>Lung</subject><subject>Lung - diagnostic imaging</subject><subject>Lung - metabolism</subject><subject>Lung - radiation effects</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - diagnostic imaging</subject><subject>Lung Neoplasms - metabolism</subject><subject>Lung Neoplasms - radiotherapy</subject><subject>LUNGS</subject><subject>Male</subject><subject>Medical sciences</subject><subject>MEDICINE</subject><subject>Middle Aged</subject><subject>Multimodal Imaging - methods</subject><subject>NANOSECONDS LIVING RADIOISOTOPES</subject><subject>NEOPLASMS</subject><subject>NUCLEAR MEDICINE</subject><subject>NUCLEI</subject><subject>ODD-ODD NUCLEI</subject><subject>Odds Ratio</subject><subject>ORGANS</subject><subject>PATHOLOGICAL CHANGES</subject><subject>Pneumology</subject><subject>PNEUMONITIS</subject><subject>POSITRON COMPUTED TOMOGRAPHY</subject><subject>Positron emission tomography (PET)</subject><subject>Positron-Emission Tomography</subject><subject>Radiation</subject><subject>RADIATION DOSES</subject><subject>RADIATION EFFECTS</subject><subject>Radiation Pneumonitis - diagnostic imaging</subject><subject>Radiation Pneumonitis - metabolism</subject><subject>Radiation-induced lung toxicity (RILT)</subject><subject>RADIOISOTOPES</subject><subject>RADIOLOGY</subject><subject>RADIOLOGY AND NUCLEAR MEDICINE</subject><subject>Radiopharmaceuticals - pharmacokinetics</subject><subject>RADIOTHERAPY</subject><subject>Respiration</subject><subject>RESPIRATORY SYSTEM</subject><subject>Respiratory system : syndromes and miscellaneous diseases</subject><subject>Retrospective Studies</subject><subject>SYMPTOMS</subject><subject>THERAPY</subject><subject>TOMOGRAPHY</subject><subject>Tomography, X-Ray Computed</subject><subject>TOXICITY</subject><subject>Tumors</subject><subject>Tumors of the respiratory system and mediastinum</subject><issn>0360-3016</issn><issn>1879-355X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFktuKFDEQhhtR3HH1DUQaRPCmx6SP6RthHVwdGA84uyCIhHRS2U1vJmmTtGy_lM9o2h4VvPEqUPmq6q_6K0keY7TGCNcv-rXqne2GdY5iCNXrGLyTrDBp2qyoqs93kxUqapQVMX6SPPC-Rwhh3JT3k5McEVLinKySH18wSc-_Sj1aZwXY2-lKj9x6SC-HwG4g_chCAGd8qky6G81V-gqkdZB-YkLZcA2ODVO6FWCCklN65oD59N0M7EfPYQiq05AG-4tnQVmTbY0YOYil2oW9VVyFaS7_Pn7uD0zrbANaL_8bZji4WYWKLfzD5J5k2sOj43uaXJ6_vti8zXYf3mw3Z7uMV1URsq4UuCNcgGwrJsuOc8A1byAXkneYFKio6orXOC84kmUhSFU2LQEiS2BMSl6cJk-XutYHRX1UCPyaW2OAB5rjqkVl3kbq-UINzn4bwQd6UHForZkBO3qK86ohcdOkiWi5oNxZ7x1IOjh1YG6iGNHZT9rTxU86-0lRTWMwpj05dhi7A4g_Sb8NjMCzI8A8Z1q6uC_l_3Jlg5qmnaW-XDiIW_uuwM1DQdytUG6eSVj1PyX_FuBaGRV73sAEvrejM9ERiqnPKaL7-fbm08Px6kgdXfkJtc3X_w</recordid><startdate>20111101</startdate><enddate>20111101</enddate><creator>Petit, Steven F., M.Sc</creator><creator>van Elmpt, Wouter J.C., Ph.D</creator><creator>Oberije, Cary J.G., M.Sc</creator><creator>Vegt, Erik, M.D</creator><creator>Dingemans, Anne-Marie C., Ph.D</creator><creator>Lambin, Philippe, M.D., Ph.D</creator><creator>Dekker, André L.A.J., Ph.D</creator><creator>De Ruysscher, Dirk, M.D., Ph.D</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope><scope>OTOTI</scope></search><sort><creationdate>20111101</creationdate><title>[18 F]fluorodeoxyglucose Uptake Patterns in Lung Before Radiotherapy Identify Areas More Susceptible to Radiation-Induced Lung Toxicity in Non-Small-Cell Lung Cancer Patients</title><author>Petit, Steven F., M.Sc ; van Elmpt, Wouter J.C., Ph.D ; Oberije, Cary J.G., M.Sc ; Vegt, Erik, M.D ; Dingemans, Anne-Marie C., Ph.D ; Lambin, Philippe, M.D., Ph.D ; Dekker, André L.A.J., Ph.D ; De Ruysscher, Dirk, M.D., Ph.D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c553t-b4d1b8cdef95af4bcce16c7e2dfcb18303565c6123c0f43d854798e8f4eaaffc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult</topic><topic>Age</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>ANTIMETABOLITES</topic><topic>BETA DECAY RADIOISOTOPES</topic><topic>BETA-PLUS DECAY RADIOISOTOPES</topic><topic>Biological and medical sciences</topic><topic>BODY</topic><topic>Carcinoma, Non-Small-Cell Lung - diagnostic imaging</topic><topic>Carcinoma, Non-Small-Cell Lung - metabolism</topic><topic>Carcinoma, Non-Small-Cell Lung - radiotherapy</topic><topic>CAT SCANNING</topic><topic>Chemoradiotherapy</topic><topic>COMPUTERIZED TOMOGRAPHY</topic><topic>DIAGNOSTIC TECHNIQUES</topic><topic>DISEASES</topic><topic>DOSES</topic><topic>DRUGS</topic><topic>Dyspnea</topic><topic>Dyspnea - etiology</topic><topic>EMISSION COMPUTED TOMOGRAPHY</topic><topic>Female</topic><topic>FLUORINE 18</topic><topic>FLUORINE ISOTOPES</topic><topic>FLUORODEOXYGLUCOSE</topic><topic>Fluorodeoxyglucose (FDG)</topic><topic>Fluorodeoxyglucose F18 - pharmacokinetics</topic><topic>HAZARDS</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>HOURS LIVING RADIOISOTOPES</topic><topic>Humans</topic><topic>HYPOTHESIS</topic><topic>INFLAMMATION</topic><topic>ISOMERIC TRANSITION ISOTOPES</topic><topic>ISOTOPES</topic><topic>LIGHT NUCLEI</topic><topic>Logistic Models</topic><topic>Lung</topic><topic>Lung - diagnostic imaging</topic><topic>Lung - metabolism</topic><topic>Lung - radiation effects</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - diagnostic imaging</topic><topic>Lung Neoplasms - metabolism</topic><topic>Lung Neoplasms - radiotherapy</topic><topic>LUNGS</topic><topic>Male</topic><topic>Medical sciences</topic><topic>MEDICINE</topic><topic>Middle Aged</topic><topic>Multimodal Imaging - methods</topic><topic>NANOSECONDS LIVING RADIOISOTOPES</topic><topic>NEOPLASMS</topic><topic>NUCLEAR MEDICINE</topic><topic>NUCLEI</topic><topic>ODD-ODD NUCLEI</topic><topic>Odds Ratio</topic><topic>ORGANS</topic><topic>PATHOLOGICAL CHANGES</topic><topic>Pneumology</topic><topic>PNEUMONITIS</topic><topic>POSITRON COMPUTED TOMOGRAPHY</topic><topic>Positron emission tomography (PET)</topic><topic>Positron-Emission Tomography</topic><topic>Radiation</topic><topic>RADIATION DOSES</topic><topic>RADIATION EFFECTS</topic><topic>Radiation Pneumonitis - diagnostic imaging</topic><topic>Radiation Pneumonitis - metabolism</topic><topic>Radiation-induced lung toxicity (RILT)</topic><topic>RADIOISOTOPES</topic><topic>RADIOLOGY</topic><topic>RADIOLOGY AND NUCLEAR MEDICINE</topic><topic>Radiopharmaceuticals - pharmacokinetics</topic><topic>RADIOTHERAPY</topic><topic>Respiration</topic><topic>RESPIRATORY SYSTEM</topic><topic>Respiratory system : syndromes and miscellaneous diseases</topic><topic>Retrospective Studies</topic><topic>SYMPTOMS</topic><topic>THERAPY</topic><topic>TOMOGRAPHY</topic><topic>Tomography, X-Ray Computed</topic><topic>TOXICITY</topic><topic>Tumors</topic><topic>Tumors of the respiratory system and mediastinum</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Petit, Steven F., M.Sc</creatorcontrib><creatorcontrib>van Elmpt, Wouter J.C., Ph.D</creatorcontrib><creatorcontrib>Oberije, Cary J.G., M.Sc</creatorcontrib><creatorcontrib>Vegt, Erik, M.D</creatorcontrib><creatorcontrib>Dingemans, Anne-Marie C., Ph.D</creatorcontrib><creatorcontrib>Lambin, Philippe, M.D., Ph.D</creatorcontrib><creatorcontrib>Dekker, André L.A.J., Ph.D</creatorcontrib><creatorcontrib>De Ruysscher, Dirk, M.D., Ph.D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>OSTI.GOV</collection><jtitle>International journal of radiation oncology, biology, physics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Petit, Steven F., M.Sc</au><au>van Elmpt, Wouter J.C., Ph.D</au><au>Oberije, Cary J.G., M.Sc</au><au>Vegt, Erik, M.D</au><au>Dingemans, Anne-Marie C., Ph.D</au><au>Lambin, Philippe, M.D., Ph.D</au><au>Dekker, André L.A.J., Ph.D</au><au>De Ruysscher, Dirk, M.D., Ph.D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>[18 F]fluorodeoxyglucose Uptake Patterns in Lung Before Radiotherapy Identify Areas More Susceptible to Radiation-Induced Lung Toxicity in Non-Small-Cell Lung Cancer Patients</atitle><jtitle>International journal of radiation oncology, biology, physics</jtitle><addtitle>Int J Radiat Oncol Biol Phys</addtitle><date>2011-11-01</date><risdate>2011</risdate><volume>81</volume><issue>3</issue><spage>698</spage><epage>705</epage><pages>698-705</pages><issn>0360-3016</issn><eissn>1879-355X</eissn><coden>IOBPD3</coden><abstract>Purpose Our hypothesis was that pretreatment inflammation in the lung makes pulmonary tissue more susceptible to radiation damage. The relationship between pretreatment [18 F]fluorodeoxyglucose ([18 F]FDG) uptake in the lungs (as a surrogate for inflammation) and the delivered radiation dose and radiation-induced lung toxicity (RILT) was investigated. Methods and Materials We retrospectively studied a prospectively obtained cohort of 101 non-small-cell lung cancer patients treated with (chemo)radiation therapy (RT). [18 F]FDG-positron emission tomography-computed tomography (PET-CT) scans used for treatment planning were studied. Different parameters were used to describe [18 F]FDG uptake patterns in the lungs, excluding clinical target volumes, and the interaction with radiation dose. An increase in the dyspnea grade of 1 (Common Terminology Criteria for Adverse Events version 3.0) or more points compared to the pre-RT score was used as an endpoint for analysis of RILT. The effect of [18 F]FDG and CT-based variables, dose, and other patient or treatment characteristics that effected RILT was studied using logistic regression. Results Increased lung density and pretreatment [18 F]FDG uptake were related to RILT after RT with univariable logistic regression. The 95th percentile of the [18 F]FDG uptake in the lungs remained significant in multivariable logistic regression ( p = 0.016; odds ratio [OR] = 4.3), together with age ( p = 0.029; OR = 1.06), and a pre-RT dyspnea score of ≥1 ( p = 0.005; OR = 0.20). Significant interaction effects were demonstrated among the 80th, 90th, and 95th percentiles and the relative lung volume receiving more than 2 and 5 Gy. Conclusions The risk of RILT increased with the 95th percentile of the [18 F]FDG uptake in the lungs, excluding clinical tumor volume (OR = 4.3). The effect became more pronounced as the fraction of the 5%, 10%, and 20% highest standardized uptake value voxels that received more than 2 Gy to 5 Gy increased. Therefore, the risk of RILT may be decreased by applying sophisticated radiotherapy techniques to avoid areas in the lung with high [18 F]FDG uptake.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>20884128</pmid><doi>10.1016/j.ijrobp.2010.06.016</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0360-3016
ispartof International journal of radiation oncology, biology, physics, 2011-11, Vol.81 (3), p.698-705
issn 0360-3016
1879-355X
language eng
recordid cdi_osti_scitechconnect_21590429
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Adult
Age
Age Factors
Aged
Aged, 80 and over
ANTIMETABOLITES
BETA DECAY RADIOISOTOPES
BETA-PLUS DECAY RADIOISOTOPES
Biological and medical sciences
BODY
Carcinoma, Non-Small-Cell Lung - diagnostic imaging
Carcinoma, Non-Small-Cell Lung - metabolism
Carcinoma, Non-Small-Cell Lung - radiotherapy
CAT SCANNING
Chemoradiotherapy
COMPUTERIZED TOMOGRAPHY
DIAGNOSTIC TECHNIQUES
DISEASES
DOSES
DRUGS
Dyspnea
Dyspnea - etiology
EMISSION COMPUTED TOMOGRAPHY
Female
FLUORINE 18
FLUORINE ISOTOPES
FLUORODEOXYGLUCOSE
Fluorodeoxyglucose (FDG)
Fluorodeoxyglucose F18 - pharmacokinetics
HAZARDS
Hematology, Oncology and Palliative Medicine
HOURS LIVING RADIOISOTOPES
Humans
HYPOTHESIS
INFLAMMATION
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LIGHT NUCLEI
Logistic Models
Lung
Lung - diagnostic imaging
Lung - metabolism
Lung - radiation effects
Lung cancer
Lung Neoplasms - diagnostic imaging
Lung Neoplasms - metabolism
Lung Neoplasms - radiotherapy
LUNGS
Male
Medical sciences
MEDICINE
Middle Aged
Multimodal Imaging - methods
NANOSECONDS LIVING RADIOISOTOPES
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
ODD-ODD NUCLEI
Odds Ratio
ORGANS
PATHOLOGICAL CHANGES
Pneumology
PNEUMONITIS
POSITRON COMPUTED TOMOGRAPHY
Positron emission tomography (PET)
Positron-Emission Tomography
Radiation
RADIATION DOSES
RADIATION EFFECTS
Radiation Pneumonitis - diagnostic imaging
Radiation Pneumonitis - metabolism
Radiation-induced lung toxicity (RILT)
RADIOISOTOPES
RADIOLOGY
RADIOLOGY AND NUCLEAR MEDICINE
Radiopharmaceuticals - pharmacokinetics
RADIOTHERAPY
Respiration
RESPIRATORY SYSTEM
Respiratory system : syndromes and miscellaneous diseases
Retrospective Studies
SYMPTOMS
THERAPY
TOMOGRAPHY
Tomography, X-Ray Computed
TOXICITY
Tumors
Tumors of the respiratory system and mediastinum
title [18 F]fluorodeoxyglucose Uptake Patterns in Lung Before Radiotherapy Identify Areas More Susceptible to Radiation-Induced Lung Toxicity in Non-Small-Cell Lung Cancer Patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T03%3A37%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%5B18%20F%5Dfluorodeoxyglucose%20Uptake%20Patterns%20in%20Lung%20Before%20Radiotherapy%20Identify%20Areas%20More%20Susceptible%20to%20Radiation-Induced%20Lung%20Toxicity%20in%20Non-Small-Cell%20Lung%20Cancer%20Patients&rft.jtitle=International%20journal%20of%20radiation%20oncology,%20biology,%20physics&rft.au=Petit,%20Steven%20F.,%20M.Sc&rft.date=2011-11-01&rft.volume=81&rft.issue=3&rft.spage=698&rft.epage=705&rft.pages=698-705&rft.issn=0360-3016&rft.eissn=1879-355X&rft.coden=IOBPD3&rft_id=info:doi/10.1016/j.ijrobp.2010.06.016&rft_dat=%3Cproquest_osti_%3E1257888487%3C/proquest_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1257888487&rft_id=info:pmid/20884128&rft_els_id=S0360301610008655&rfr_iscdi=true